CNASHighly Regulated (List I)TranslatedNOLVADEX
ASTRAZENECA
Identification
- Active ingredient (INN)
- TAMOXIFENE SOUS FORME DE CITRATE DE TAMOXIFENE
- Internal code
- 05 E 135
- Country of Origin
- France
- Pharmaceutical form
- Film-coated Tablet
- Prescription List
- Highly Regulated (List I)
- Packaging
- b/30
CNASDAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Indications
Used in treatment: widespread breast cancer as an auxiliary post-extermination treatment to reduce the risk of cancer in women with chronic breast cancer to protect against breast cancer in women with risk factors.
Associated Conditions
The health category of pregnancy: "D"; treatment is not recommended during pregnancy, as it can harm the baby, and pregnancy must be avoided during treatment.
Mechanism of Action
Linked to the receptors of estrogen to cancer cells, which prevents estrogen from being associated with them and thus its effect on cells, which limits cancer tumor growth.
Do you have questions on this subject? Ask Sina, artificial intelligence to answer all your medical questions.
Write your question here, Sina, prepare the answer for you.